Alpha Tau Medical DRTS
NASDAQ DRTS
$15.00 +0.38 (+2.60%)
As of: Sep 4, 2026 · 3:18 PM EDT

Alpha Tau Medical (DRTS) Non Operating Income (2021 - 2026)

Alpha Tau Medical (DRTS) posted Non Operating Income of -$867000.0 for Q4 2025, down 189.94% sequentially from $964000.0 in Q3 2025, and down 111.12% YoY from $7.8 million in Q4 2024.

Analysis

Alpha Tau Medical (DRTS) Non Operating Income (2021 - 2026) Analysis & Trends

Alpha Tau Medical has reported Non Operating Income for 5 years, with the latest figure at -$867000.0 in Q4 2025.

  • Quarterly Non Operating Income fell 111.12% year-over-year to -$867000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$218000.0 (down 105.07% YoY) and the FY2025 annual result came in at -$218000.0, down 105.07% from the prior year.
  • Non Operating Income retreated to -$867000.0 in Q4 2025 per DRTS's latest filing, from $964000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $17.0 million in Q1 2022 and troughed at -$6.0 million in Q2 2022.
  • A 5-year average of $1.2 million and a median of -$478000.0 in 2023 frame the typical range for Non Operating Income.
  • The sharpest annual moves came in 2023 and 2024: Non Operating Income jumped 328.48% in 2023, then tumbled 438.28% in 2024.
  • Over 5 years, Non Operating Income stood at $9.0 million in 2021, then plunged by 151.22% to -$4.6 million in 2022, then surged by 328.48% to $10.5 million in 2023, then retreated by 25.7% to $7.8 million in 2024, then sank by 111.12% to -$867000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods registered -$867000.0, $964000.0, and $401000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -
5 Revolution Medicines 44.02 Bn 44.02 Bn - -139.24 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - -51.63 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
10 Alpha Tau Medical 1.21 Bn 1.11 Bn - 31.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.80 Mn
Mar 31, 2026 9.64 Mn
Dec 31, 2025 -894,000.00
Sep 30, 2025 964,000.00
Jun 30, 2025 401,000.00
Mar 31, 2025 -716,000.00
Dec 31, 2024 3.54 Mn
Sep 30, 2024 -1.37 Mn
Jun 30, 2024 -1.69 Mn
Mar 31, 2024 -444,000.00
Dec 31, 2023 5.69 Mn
Sep 30, 2023 -4.46 Mn
Jun 30, 2023 987,000.00
Mar 31, 2023 -478,000.00
Dec 31, 2022 -7.52 Mn
Sep 30, 2022 -4.74 Mn
Jun 30, 2022 -6.02 Mn
Mar 31, 2022 16.96 Mn
Dec 31, 2021 -13.59 Mn
Sep 30, 2021 1.17 Mn